Patent · US Active

Miniaturized dystrophins having spectrin fusion domains and uses thereof

US11535868B2 · kind B2 · utility

0Cited by

24References

26Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

Glen BANKS · Yardley, US
Jonathan Davis · Waltham, US
Paul C. Levesque · Yardley, US

Key dates

Filing date	Apr 28, 2021
Grant date	Dec 27, 2022
Priority date	—
Expiry date	Apr 28, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2830/50
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are nucleic acid molecules, polypeptides, cells, vectors, and pharmaceutical compositions relating to miniaturized dystrophin. Methods of production and methods of therapeutic use of the miniaturized dystrophin are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.